HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sheng-Hung Wang Selected Research

Endonucleases

1/2019Effects of APE1 Asp148Glu polymorphisms on OPMD malignant transformation, and on susceptibility to and overall survival of oral cancer in Taiwan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sheng-Hung Wang Research Topics

Disease

13Neoplasms (Cancer)
12/2022 - 03/2014
4Breast Neoplasms (Breast Cancer)
01/2021 - 12/2014
3Stroke (Strokes)
11/2022 - 04/2017
2Chronic Obstructive Pulmonary Disease (COPD)
06/2022 - 09/2020
2Neoplasm Metastasis (Metastasis)
01/2021 - 07/2019
2Inflammation (Inflammations)
09/2014 - 03/2014
1Esophageal Squamous Cell Carcinoma
09/2023
1Traumatic Brain Injuries (Traumatic Brain Injury)
11/2022
1Ischemia
11/2022
1Diabetic Retinopathy (Retinopathy, Diabetic)
10/2022
1Edema (Dropsy)
01/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2021
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2021
1Neuroblastoma
11/2020
1Lung Neoplasms (Lung Cancer)
09/2020
1Dyslipidemias (Dyslipidemia)
01/2019
1Mouth Neoplasms (Oral Cancer)
01/2019
1Myocardial Infarction
01/2019
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2018
1Ankylosing Spondylitis
08/2017
1Cognitive Dysfunction
04/2017
1Hepatitis
09/2014
1Foodborne Diseases
09/2014
1Periodontitis
08/2014
1Hypertension (High Blood Pressure)
03/2014
1Bacterial Infections (Bacterial Infection)
03/2014
1Ganglion Cysts (Ganglion)
01/2009

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2014
3Globo-HIBA
11/2020 - 12/2014
3CeramidesIBA
11/2020 - 12/2014
3Peptides (Polypeptides)IBA
01/2018 - 01/2016
2CollagenIBA
06/2022 - 09/2020
2Glycoproteins (Glycoprotein)IBA
01/2021 - 09/2020
2Polysaccharides (Glycans)IBA
01/2021 - 09/2020
2GlycolipidsIBA
11/2020 - 12/2014
2GlycosphingolipidsIBA
11/2020 - 09/2020
2Endoplasmic Reticulum Chaperone BiPIBA
01/2018 - 01/2016
1matrigelIBA
12/2022
1Indicators and Reagents (Reagents)IBA
10/2022
1EnzymesIBA
06/2022
1NucleophosminIBA
01/2022
1MorpholinosIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1GlycosyltransferasesIBA
01/2021
1OligosaccharidesIBA
01/2021
1Immune Checkpoint ProteinsIBA
01/2021
1dinutuximabIBA
11/2020
1Cysteine (L-Cysteine)FDA Link
09/2020
1SmokeIBA
01/2019
1omega-Chloroacetophenone (Mace)IBA
01/2019
1EndonucleasesIBA
01/2019
1HLA Antigens (Human Leukocyte Antigens)IBA
08/2017
1KIR ReceptorsIBA
08/2017
1TeaIBA
04/2017
1Liposomes (Liposome)IBA
06/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1Carrier Proteins (Binding Protein)IBA
01/2016
1TubulinIBA
01/2016
1Factor X (Stuart Factor)IBA
12/2014
1ElementsIBA
12/2014
1AntidotesIBA
09/2014
1Concanavalin AIBA
09/2014
1zhankuic acid AIBA
09/2014
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
08/2014
1Fatty Acids (Saturated Fatty Acids)IBA
08/2014
1Retinaldehyde (Retinal)IBA
01/2009

Therapy/Procedure

8Therapeutics
11/2022 - 12/2014
2Chemoradiotherapy
09/2023 - 01/2021
2Immunotherapy
11/2020 - 09/2020
2Traditional Medicine (Folk Remedies)
09/2014 - 03/2014
1Acupuncture Therapy
11/2022
1Precision Medicine
01/2022
1Radiotherapy
07/2019
1Drug Therapy (Chemotherapy)
07/2019
1Critical Care (Surgical Intensive Care)
01/2018
1Aftercare (After-Treatment)
08/2014